Brighthouse Financial, Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Brighthouse Financial, Inc. reported revenue of $6.8B (+43.2% year on year) and net income of $438.0M (+11.5% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Premiums | $695.0M | $770.0M | $828.0M | $662.0M |
| Universal life and investment-type product policy fees | $2.2B | $2.1B | $2.3B | $3.1B |
| Net investment income | $5.2B | $5.2B | $4.7B | $4.1B |
| Other revenues | $555.0M | $579.0M | $483.0M | $476.0M |
| Net investment gains (losses) | ($97.0M) | ($295.0M) | ($246.0M) | ($248.0M) |
| Net derivative gains (losses) | ($1.8B) | ($3.7B) | ($3.9B) | $304.0M |
| Total revenues | $6.8B | $4.7B | $4.1B | $8.5B |
| Policyholder benefits and claims (including liability remeasurement gains (losses) of ($273), ($978), ($234), respectively) | $1.8B | $2.3B | $2.7B | $4.2B |
| Interest credited to policyholder account balances | $2.2B | $2.1B | $1.8B | $1.4B |
| Amortization of deferred policy acquisition costs and value of business acquired | $609.0M | $599.0M | $620.0M | $956.0M |
| Change in market risk benefits | ($268.0M) | ($2.7B) | ($1.5B) | — |
| Other expenses | $2.0B | $1.9B | $2.0B | $2.1B |
| Total expenses | $6.3B | $4.3B | $5.6B | $8.6B |
| Income (loss) before provision for income tax | $474.0M | $422.0M | ($1.5B) | ($172.0M) |
| Provision for income tax expense (benefit) | $36.0M | $29.0M | ($367.0M) | ($182.0M) |
| Net income (loss) | $438.0M | $393.0M | ($1.1B) | $10.0M |
| Net income (loss) attributable to noncontrolling interests | $5.0M | $5.0M | $5.0M | $5.0M |
| Net income (loss) attributable to Brighthouse Financial, Inc. | $433.0M | $388.0M | ($1.1B) | $5.0M |
| Preferred stock dividends | $102.0M | $102.0M | $102.0M | $104.0M |
| Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $331.0M | $286.0M | ($1.2B) | ($99.0M) |
| Basic | $5.75 | $4.67 | -$18.39 | -$1.36 |
| Diluted | $5.71 | $4.64 | -$18.39 | -$1.36 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Premiums | $165.0M | $168.0M | $170.0M | $166.0M |
| Universal life and investment-type product policy fees | $570.0M | $533.0M | $531.0M | $553.0M |
| Net investment income | $1.2B | $1.3B | $1.3B | $1.3B |
| Other revenues | $129.0M | $129.0M | $143.0M | $143.0M |
| Net investment gains (losses) | ($6.0M) | ($52.0M) | $48.0M | ($39.0M) |
| Net derivative gains (losses) | ($477.0M) | ($509.0M) | ($410.0M) | ($1.2B) |
| Total revenues | $1.6B | $1.5B | $1.8B | $871.0M |
| Policyholder benefits and claims (including liability remeasurement gains (losses) of $0, $0, $0 and $0, respectively) | $591.0M | $637.0M | ($252.0M) | $711.0M |
| Interest credited to policyholder account balances | $531.0M | $493.0M | $561.0M | $537.0M |
| Amortization of deferred policy acquisition costs and value of business acquired | $157.0M | $158.0M | $153.0M | $149.0M |
| Change in market risk benefits | ($1.4B) | $748.0M | $289.0M | ($1.1B) |
| Other expenses | $487.0M | $477.0M | $480.0M | $482.0M |
| Total expenses | $396.0M | $2.5B | $1.2B | $778.0M |
| Income (loss) before provision for income tax | $1.2B | ($986.0M) | $585.0M | $93.0M |
| Provision for income tax expense (benefit) | $245.0M | ($222.0M) | $104.0M | $8.0M |
| Net income (loss) | $981.0M | ($764.0M) | $481.0M | $85.0M |
| Net income (loss) attributable to noncontrolling interests | $0 | $2.0M | $2.0M | $0 |
| Net income (loss) attributable to Brighthouse Financial, Inc. | $981.0M | ($766.0M) | $479.0M | $85.0M |
| Preferred stock dividends | $25.0M | $26.0M | $26.0M | $25.0M |
| Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $956.0M | ($792.0M) | $453.0M | $60.0M |
| Comprehensive income (loss) | $1.0B | ($1.2B) | $718.0M | $498.0M |
| Less: Comprehensive income (loss) attributable to noncontrolling interests | $0 | $2.0M | $2.0M | $0 |
| Comprehensive income (loss) attributable to Brighthouse Financial, Inc. | $1.0B | ($1.2B) | $716.0M | $498.0M |
| Basic | $16.62 | -$13.82 | $7.93 | $1.03 |
| Diluted | $16.53 | -$13.82 | $7.89 | $1.02 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $87,046 and $87,603, respectively; allowance for credit losses of $64 and $81, respectively) | $82.0B | $80.1B | $81.0B | $75.6B |
| Trading securities, at estimated fair value | $506.0M | — | — | — |
| Equity securities, at estimated fair value | $79.0M | $77.0M | $102.0M | $89.0M |
| Mortgage loans (net of allowance for credit losses of $200 and $178, respectively) | $22.8B | $23.3B | $22.5B | $22.9B |
| Policy loans | $1.4B | $2.0B | $1.3B | $1.3B |
| Limited partnerships and limited liability companies | $4.7B | $4.8B | $4.9B | $4.8B |
| Short-term investments, principally at estimated fair value | $1.2B | $1.9B | $1.2B | $1.1B |
| Other invested assets, principally at estimated fair value (net of allowance for credit losses of $0 and $0, respectively) | $7.9B | $5.3B | $4.4B | $2.9B |
| Total investments | $120.6B | $117.4B | $115.5B | $108.6B |
| Cash and cash equivalents | $5.4B | $5.0B | $3.9B | $4.1B |
| Accrued investment income | $1.3B | $1.3B | $1.2B | $885.0M |
| Premiums, reinsurance and other receivables (net of allowance for credit losses of $3 and $3, respectively) | $21.6B | $21.1B | $19.8B | $19.3B |
| Deferred policy acquisition costs and value of business acquired | $4.6B | $4.7B | $4.9B | $5.7B |
| Current income tax recoverable | $16.0M | $19.0M | $27.0M | $38.0M |
| Deferred income tax asset | $1.4B | $1.9B | $1.9B | $1.6B |
| Market risk benefit assets | $1.1B | $1.1B | $656.0M | — |
| Other assets | $332.0M | $370.0M | $370.0M | $442.0M |
| Separate account assets | $85.5B | $85.6B | $88.3B | $85.0B |
| Total assets | $241.8B | $238.5B | $236.3B | $225.6B |
| Future policy benefits | $32.0B | $31.5B | $32.6B | $41.6B |
| Policyholder account balances | $88.0B | $88.0B | $81.1B | $74.8B |
| Market risk benefit liabilities | $8.1B | $8.3B | $10.3B | — |
| Other policy-related balances | $3.9B | $3.9B | $3.8B | $3.4B |
| Payables for collateral under securities loaned and other transactions | $4.7B | $3.9B | $3.7B | $4.6B |
| Long-term debt | $3.2B | $3.2B | $3.2B | $3.2B |
| Other liabilities | $9.6B | $9.2B | $8.4B | $7.1B |
| Separate account liabilities | $85.5B | $85.6B | $88.3B | $85.0B |
| Total liabilities | $235.0B | $233.5B | $231.3B | $219.5B |
| Preferred stock, par value $0.01 per share; $1,753 aggregate liquidation preference | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, par value $0.01 per share; 1,000,000,000 shares authorized; 124,081,967 and 123,480,326 shares issued, respectively; 57,171,217 and 58,629,049 shares outstanding, respectively | $1000000.00 | $1000000.00 | $1000000.00 | $1000000.00 |
| Additional paid-in capital | $13.9B | $13.9B | $14.0B | $14.1B |
| Retained earnings (deficit) | ($686.0M) | ($1.1B) | ($1.5B) | ($637.0M) |
| Treasury stock, at cost; 66,910,750 and 64,851,277 shares, respectively | -2.7B | -2.6B | -2.3B | -2.0B |
| Accumulated other comprehensive income (loss) | ($3.7B) | ($5.3B) | ($5.2B) | ($5.4B) |
| Total Brighthouse Financial, Inc.’s stockholders’ equity | $6.8B | $5.0B | $4.9B | $6.0B |
| Noncontrolling interests | $65.0M | $65.0M | $65.0M | $65.0M |
| Total equity | $6.8B | $5.0B | $5.0B | $6.0B |
| Total liabilities and equity | $241.8B | $238.5B | $236.3B | $225.6B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $86,653 and $87,046, respectively; allowance for credit losses of $64 and $64, respectively) | $80.8B | $81.2B | $81.5B | $80.8B |
| Trading securities, at estimated fair value | $596.0M | $544.0M | $528.0M | $520.0M |
| Equity securities, at estimated fair value | $83.0M | $76.0M | $78.0M | $74.0M |
| Mortgage loans (net of allowance for credit losses of $220 and $200, respectively) | $22.6B | $22.6B | $22.9B | $23.0B |
| Policy loans | $1.5B | $1.5B | $1.4B | $1.4B |
| Limited partnerships and limited liability companies | $4.6B | $4.7B | $4.8B | $4.8B |
| Short-term investments, principally at estimated fair value | $960.0M | $1.2B | $778.0M | $1.2B |
| Other invested assets, principally at estimated fair value (net of allowance for credit losses of $0 and $0, respectively) | $13.9B | $9.6B | $8.8B | $8.9B |
| Total investments | $125.0B | $121.5B | $120.9B | $120.7B |
| Cash and cash equivalents | $7.1B | $4.9B | $6.6B | $5.5B |
| Accrued investment income | $1.2B | $1.3B | $1.4B | $1.2B |
| Premiums, reinsurance and other receivables (net of allowance for credit losses of $3 and $3, respectively) | $20.8B | $20.8B | $21.2B | $21.3B |
| Deferred policy acquisition costs and value of business acquired | $4.5B | $4.5B | $4.6B | $4.6B |
| Current income tax recoverable | $10.0M | $16.0M | $17.0M | $17.0M |
| Deferred income tax asset | $1.5B | $1.8B | $1.5B | $1.7B |
| Market risk benefit assets | $1.0B | $850.0M | $979.0M | $1.1B |
| Other assets | $303.0M | $324.0M | $342.0M | $348.0M |
| Separate account assets | $85.7B | $80.8B | $87.1B | $86.1B |
| Total assets | $247.2B | $236.8B | $244.7B | $242.6B |
| Future policy benefits | $31.9B | $31.8B | $32.0B | $32.0B |
| Policyholder account balances | $89.1B | $86.4B | $88.7B | $88.0B |
| Market risk benefit liabilities | $7.4B | $8.6B | $8.5B | $8.1B |
| Other policy-related balances | $3.8B | $4.0B | $3.9B | $4.0B |
| Payables for collateral under securities loaned and other transactions | $6.8B | $4.7B | $4.3B | $4.0B |
| Long-term debt | $3.2B | $3.2B | $3.2B | $3.2B |
| Other liabilities | $12.6B | $11.8B | $10.5B | $11.6B |
| Separate account liabilities | $85.7B | $80.8B | $87.1B | $86.1B |
| Total liabilities | $240.6B | $231.2B | $238.3B | $236.9B |
| Preferred stock, par value $0.01 per share; $1,753 aggregate liquidation preference | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, par value $0.01 per share; 1,000,000,000 shares authorized; 124,637,731 and 124,081,967 shares issued, respectively; 57,508,193 and 57,171,217 shares outstanding, respectively | $1000000.00 | $1000000.00 | $1000000.00 | $1000000.00 |
| Additional paid-in capital | $13.8B | $13.9B | $13.9B | $13.9B |
| Retained earnings (deficit) | ($471.0M) | ($1.5B) | ($823.0M) | ($1.3B) |
| Treasury stock, at cost; 67,129,538 and 66,910,750 shares, respectively | -2.7B | -2.7B | -2.7B | -2.7B |
| Accumulated other comprehensive income (loss) | ($4.1B) | ($4.2B) | ($4.0B) | ($4.3B) |
| Total Brighthouse Financial, Inc.’s stockholders’ equity | $6.5B | $5.6B | $6.4B | $5.7B |
| Noncontrolling interests | $65.0M | $65.0M | $65.0M | $65.0M |
| Total equity | $6.6B | $5.6B | $6.4B | $5.7B |
| Total liabilities and equity | $247.2B | $236.8B | $244.7B | $242.6B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $438.0M | $393.0M | ($1.1B) | $10.0M |
| Amortization of premiums and accretion of discounts associated with investments, net | ($320.0M) | ($330.0M) | ($282.0M) | ($233.0M) |
| (Gains) losses on investments, net | $51.0M | $264.0M | $232.0M | $248.0M |
| (Gains) losses on derivatives, net | ($1.4B) | $1.4B | $2.6B | ($153.0M) |
| (Income) loss from equity method investments, net of dividends and distributions | ($24.0M) | $41.0M | $83.0M | $110.0M |
| Interest credited to policyholder account balances | $2.2B | $2.1B | $1.8B | $1.4B |
| Universal life and investment-type product policy fees | ($2.2B) | ($2.1B) | ($2.3B) | ($3.1B) |
| Change in market risk benefits, net | $209.0M | ($2.1B) | ($875.0M) | — |
| Change in accrued investment income | $142.0M | ($113.0M) | ($215.0M) | ($113.0M) |
| Change in premiums, reinsurance and other receivables | ($400.0M) | ($1.5B) | ($1.3B) | ($3.1B) |
| Change in deferred policy acquisition costs and value of business acquired, net | $143.0M | $162.0M | $211.0M | $531.0M |
| Change in income tax | $33.0M | $30.0M | ($371.0M) | ($234.0M) |
| Change in other assets | $1.1B | $1.2B | $1.1B | $1.8B |
| Change in future policy benefits and other policy-related balances | ($295.0M) | ($281.0M) | $51.0M | $1.5B |
| Change in other liabilities | $420.0M | $402.0M | $95.0M | $178.0M |
| Other, net | $49.0M | $30.0M | $39.0M | $32.0M |
| Net cash provided by (used in) operating activities | $259.0M | ($290.0M) | ($137.0M) | ($1.2B) |
| Sales, maturities and repayments of fixed maturity securities | $12.7B | $11.7B | $6.0B | $10.7B |
| Sales, maturities and repayments of trading securities | $44.0M | — | — | — |
| Sales, maturities and repayments of equity securities | $39.0M | $46.0M | $33.0M | $53.0M |
| Sales, maturities and repayments of mortgage loans | $2.5B | $1.5B | $1.2B | $2.1B |
| Sales, maturities and repayments of limited partnerships and limited liability companies | $570.0M | $337.0M | $205.0M | $252.0M |
| Purchases of fixed maturity securities | ($12.4B) | ($12.0B) | ($8.9B) | ($15.8B) |
| Purchases of trading securities | ($199.0M) | — | — | — |
| Purchases of equity securities | ($21.0M) | ($7.0M) | ($14.0M) | ($37.0M) |
| Purchases of mortgage loans | ($2.2B) | ($2.4B) | ($813.0M) | ($5.3B) |
| Purchases of limited partnerships and limited liability companies | ($278.0M) | ($299.0M) | ($453.0M) | ($814.0M) |
| Cash received in connection with freestanding derivatives | $16.8B | $12.5B | $5.1B | $4.5B |
| Cash paid in connection with freestanding derivatives | ($18.3B) | ($11.9B) | ($5.4B) | ($4.3B) |
| Net change in policy loans | $574.0M | ($692.0M) | ($49.0M) | ($18.0M) |
| Net change in short-term investments | $712.0M | ($675.0M) | ($38.0M) | $772.0M |
| Net change in other invested assets | $15.0M | ($372.0M) | ($112.0M) | ($376.0M) |
| Other, net | $0 | ($4.0M) | — | — |
| Net cash provided by (used in) investing activities | $751.0M | ($2.2B) | ($3.2B) | ($8.3B) |
| Policyholder account balances: Deposits | $20.2B | $30.4B | $22.0B | $31.6B |
| Policyholder account balances: Withdrawals | ($21.0B) | ($26.4B) | ($17.7B) | ($20.1B) |
| Net change in payables for collateral under securities loaned and other transactions | $814.0M | $221.0M | ($890.0M) | ($1.7B) |
| Long-term debt repaid | ($2.0M) | ($2.0M) | ($2.0M) | ($3.0M) |
| Dividends on preferred stock | ($102.0M) | ($102.0M) | ($102.0M) | ($104.0M) |
| Treasury stock acquired in connection with share repurchases | ($102.0M) | ($250.0M) | ($250.0M) | ($488.0M) |
| Financing element on certain derivative instruments and other derivative related transactions, net | ($443.0M) | ($204.0M) | $90.0M | ($185.0M) |
| Other, net | ($17.0M) | ($17.0M) | ($19.0M) | ($16.0M) |
| Net cash provided by (used in) financing activities | ($668.0M) | $3.7B | $3.1B | $9.1B |
| Change in cash, cash equivalents and restricted cash | $342.0M | $1.2B | ($264.0M) | ($359.0M) |
| Cash, cash equivalents and restricted cash, beginning of year | $5.0B | $3.9B | $4.1B | $4.5B |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net cash provided by (used in) operating activities | ($652.0M) | ($221.0M) | $262.0M | $145.0M |
| Sales, maturities and repayments of fixed maturity securities | $7.1B | $3.4B | $9.6B | $6.2B |
| Sales, maturities and repayments of trading securities | $33.0M | $22.0M | $27.0M | $6.0M |
| Sales, maturities and repayments of equity securities | $4.0M | $2.0M | $36.0M | $30.0M |
| Sales, maturities and repayments of mortgage loans | $1.6B | $825.0M | $1.6B | $1.1B |
| Sales, maturities and repayments of limited partnerships and limited liability companies | $162.0M | $79.0M | $392.0M | $196.0M |
| Purchases of fixed maturity securities | ($6.4B) | ($3.5B) | ($8.7B) | ($5.4B) |
| Purchases of trading securities | ($128.0M) | ($68.0M) | ($198.0M) | ($178.0M) |
| Purchases of equity securities | $0 | $0 | ($20.0M) | ($20.0M) |
| Purchases of mortgage loans | ($1.5B) | ($664.0M) | ($1.4B) | ($896.0M) |
| Purchases of limited partnerships and limited liability companies | ($101.0M) | ($54.0M) | ($216.0M) | ($118.0M) |
| Cash received in connection with freestanding derivatives | $10.4B | $4.8B | $12.1B | $5.3B |
| Cash paid in connection with freestanding derivatives | ($12.0B) | ($5.3B) | ($12.9B) | ($7.0B) |
| Net change in policy loans | ($5.0M) | ($9.0M) | $585.0M | $599.0M |
| Net change in short-term investments | $251.0M | ($33.0M) | $1.1B | $730.0M |
| Net change in other invested assets | ($6.0M) | $1.0M | $10.0M | $11.0M |
| Net cash provided by (used in) investing activities | ($582.0M) | ($485.0M) | $2.0B | $675.0M |
| Policyholder account balances: Deposits | $14.0B | $7.0B | $14.6B | $9.8B |
| Policyholder account balances: Withdrawals | ($13.2B) | ($6.7B) | ($15.2B) | ($10.0B) |
| Net change in payables for collateral under securities loaned and other transactions | $2.1B | ($44.0M) | $456.0M | $103.0M |
| Long-term debt repaid | ($1.0M) | ($1.0M) | ($1.0M) | ($1.0M) |
| Dividends on preferred stock | ($51.0M) | ($26.0M) | ($77.0M) | ($51.0M) |
| Treasury stock acquired in connection with share repurchases | $0 | $0 | ($102.0M) | ($102.0M) |
| Financing element on certain derivative instruments and other derivative related transactions, net | $125.0M | $24.0M | ($371.0M) | ($114.0M) |
| Other, net | ($16.0M) | ($13.0M) | $0 | ($14.0M) |
| Net cash provided by (used in) financing activities | $3.0B | $226.0M | ($748.0M) | ($325.0M) |
| Change in cash, cash equivalents and restricted cash | $1.7B | ($480.0M) | $1.6B | $495.0M |
| Cash, cash equivalents and restricted cash, beginning of period | $5.4B | $5.4B | $5.0B | $5.0B |
| Cash, cash equivalents and restricted cash, end of period | $7.1B | $4.9B | $6.6B | $5.5B |
| Net cash paid (received) for interest | $75.0M | $6.0M | $82.0M | $75.0M |
| Net cash paid (received) for income tax | $7.0M | $4.0M | $12.0M | $10.0M |
Brighthouse Financial, Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.